香港六合彩

A UK鈥揑ndia collaboration is changing the way patients are screened for diabetes-related sight loss and helping to reduce the burden of blindness in India.

More than听70 million people in India听have听diabetes.听A common complication听of听the disease听is sight-threatening diabetic retinopathy (STDR), which is听the听main听cause of blindness in working-age听people in India.听

Nearly 80% of adults听with听diabetes reside in LMIC where primary care infrastructure听is in its infancy, fuelling the global challenge of听managing听diabetes and its complications.听听

鈥淐omplications of diabetes听need to be听identified听and treated听early听to reduce the impact of blindness on quality of life and听the nation鈥檚 economy,鈥澨齭ays Sobha Sivaprasad, Professor of Retinal Clinical Studies (香港六合彩 Institute of Ophthalmology)听and Consultant Ophthalmologist at Moorfields Eye Hospital, London.听听

Professor Sivaprasad is leading a programme of research听called听ORNATE India, funded through UKRI鈥檚 Global Challenges Research Fund,听to听build research capacity and capability in India and the UK to tackle听the听global burden of diabetes-related visual impairment.听

The multidisciplinary team in the UK and India听is听developing a range of听strategies and methods听could听change the face of diabetes-related healthcare in听India.听

鈥�鈥淐omplications of diabetes听need to be听identified and treated听early听to reduce the impact of blindness on quality of life and the nation鈥檚 economy.鈥澨�

鈥淲e鈥檝e听set out ambitious plans听to听establish new care pathways,听develop affordable technologies,听reduce variations听in the quality of care听and analyse the economic impact of various interventions,鈥� Professor Sivaprasad听explains听

鈥淲e are testing a novel听diabetic retinopathy听screening programme in a district in Kerala听State听and are developing听new听holistic screening for diabetes and its complications in 20 areas in听India.鈥澨�

The technology听combines听a听hand-held camera with smartphone technology and automated grading,听which听helps听reduce听costs and makes听screening accessible to individuals who are unable to travel to large well-equipped centres.听

鈥淲e are also听developing听a听blood test听that patients can administer themselves to identify听markers of听STDR and other complications of diabetes. This听technology听has the potential to revolutionise the way people with diabetes听are treated听globally,鈥澨齭he adds.听